| 1 |
Wang F, Xuan XY, Yang X, et al (2014). Stathmin is a marker of progression and poor prognosis in esophageal carcinoma. Asian Pac J Cancer Prev, 15, 3613-8.
과학기술학회마을
DOI
|
| 2 |
Akhtar J, Wang Z, Jiang WP, et al (2014a). Stathmin overexpression identifies high risk for lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma patients. J Gastroenterol Hepatol, 29, 944-50.
DOI
|
| 3 |
Akhtar J, Wang Z, Yu C, et al (2014b). STMN-1 is a potential marker of lymph node metastasis in distal esophageal adenocarcinomas and silencing its expression can reverse malignant phenotype of tumor cells. BMC Cancer, 14, 28.
DOI
|
| 4 |
Akhtar J, Wang Z, Yu C, et al (2014c). Effectiveness of local injection of lentivirus-delivered stathmin shRNA in human gastric cancer xenograft mouse. J Gastroenterol Hepatol, [Epub ahead of print].
|
| 5 |
Belletti B, Baldassarre G (2011). Stathmin: a protein with many tasks. New biomarker and potential target in cancer. Expert Opin Ther Targets, 15, 1249-66.
DOI
|
| 6 |
Holmfeldt P, Brannstrom K, Stenmark S, et al (2006). Aneugenic activity of Op18/stathmin is potentiated by the somatic Q18-->e mutation in leukemic cells. Mol Biol Cell, 17, 2921-30.
DOI
|
| 7 |
Liu F, Sun YL, Xu Y, et al (2013). Expression and phosphorylation of stathmin correlate with cell migration in esophageal squamous cell carcinoma. Oncol Rep, 29, 419-24.
|
| 8 |
Misek DE, Chang CL, Kuick R, et al (2002). Transforming properties of a Q18-->E mutation of the microtubule regulator Op18. Cancer Cell, 2, 217-28.
DOI
|
| 9 |
Phadke AP, Jay CM, Wang Z, et al (2011). In vivo safety and antitumor efficacy of bifunctional small hairpin RNAs specific for the human Stathmin 1 oncoprotein. DNA Cell Biol, 30, 715-26.
DOI
|
| 10 |
Shi X, Wang D, Ding K, et al (2010). GDP366, a novel small molecule dual inhibitor of survivin and Op18, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cells. Cancer Biol Ther, 9, 640-50.
DOI
|
| 11 |
Wang F, Wang LX, Li SL, et al (2011). Downregulation of stathmin is involved in malignant phenotype reversion and cell apoptosis in esophageal squamous cell carcinoma. J Surg Oncol, 103, 704-15.
DOI
|
webmaster
